Thrombolytic effect of lonomin V in a rabbit jugular vein thrombosis model

Abstract

Thrombolytic efficacy of lonomin V (LV), a protein isolated from Lonomia achelous caterpillars haemolymph, administered either as a single intravenous bolus or as a continuous infusion, was evaluated in a rabbit jugular vein thrombosis model, and compared with those of single-chain tissue-type plasminogen activator (sct-PA) and two-chain urokinase-type plasminogen activator (tcu-PA). As a bolus LV, at doses of 100 000 IU/kg body weight (bw) produced an activator-induced thrombolysis (AIL) of 50.94% +/- 12.4 compared with 14.4% +/- 10.8 for tcu-PA at the same dose. As a continuous infusion at doses of 200 000 IU/kg bw LV produced an AIL of 45.8%, whereas sct-PA and tcu-PA produced an AIL of 69.9 and 33.7%, respectively. Fibrinogen, plasminogen and alpha-2-antiplasmin levels decreased significantly with the higher doses of LV, sct-PA, and tcu-PA. Factor XIII levels were significantly reduced in a dose-dependent manner only with LV. In conclusion, LV produces a dose-dependent thrombolysis in combination with a decrease in factor XIII activity.

<i>Lonomia</i> Genus Caterpillar Envenomation: Clinical and Biological Aspects

“…Intravenous injections of lonomin I/V induce a dose-dependent thrombolysis of preformed thrombi in combination with a decrease in Fg, plasminogen, · 2 -antiplasmin and FXIII, without an increase in Fg degradation products nor any bleeding manifestations [33]. The thrombolytic effect is followed by an inhibition of 125 I-fibrinogen accretion [34].…”